Bulk Pharmaceutical API Sources for TWIRLA

Bulk Pharmaceutical API Sources for TWIRLA

Vendor	Vendor Homepage	Vendor Sku	API Url
ABI Chem		AC1L2NM9
J&H Chemical Co.,ltd		JH285923
RR Scientific		R207957
AKos Consulting & Solutions		AKOS040751734

Bulk API Sources for TWIRLA

Last updated: February 20, 2026

TWIRLA is a contraceptive transdermal system combining ethinyl estradiol and levonorgestrel. As a combination product, its active pharmaceutical ingredients (APIs) include ethinyl estradiol and levonorgestrel. Sourcing bulk APIs involves assessing reliable suppliers, regulatory compliance, and manufacturing capacities.

API Composition and Specifications

API	Quantity per patch	Typical purity	Regulatory compliance	Supply stability
Ethinyl estradiol	0.035 mg	≥ 99%	EMA, FDA approved	Widely available
Levonorgestrel	0.15 mg	≥ 99%	EMA, FDA approved	Multiple global sources

Major API Suppliers

Ethinyl Estradiol

• Huwel Biotech Ltd. (India): Produces high-purity ethinyl estradiol, ISO 9001, cGMP-certified. Supplies include bulk APIs for contraceptives. Leads in API manufacturing capacity in Asia, with delivery lead times of 8-12 weeks.

• Hangzhou Dajiang Biochemical Co. Ltd. (China): Offers certified ethinyl estradiol APIs, with a focus on quality compliance. Known for rapid production cycles, ensuring delivery within 4-6 weeks for small to medium orders.

• Triveni Synthetic and Pharmaceuticals (India): Provides APIs with validated social and environmental compliance. Capable of large volumes with consistent quality, supported by ISO 9001 and cGMP certifications.

Levonorgestrel

• Bionpharma, Inc. (USA): Supplies high-grade levonorgestrel APIs used in contraceptive drugs. Emphasizes regulatory alignment with FDA standards, reliable supply chain with lead times around 10 weeks.

• Hubei Biocause Pharmaceutical Co., Ltd. (China): Offers cost-competitive levonorgestrel APIs, with ISO 9001 and cGMP certifications. Production capacity exceeds 50 tons annually.

• Sichuan Kexin Pharmaceutical Co., Ltd. (China): Provides levonorgestrel APIs with maintained strict quality control. Leads time for large orders is approximately 8-12 weeks.

Regulatory and Quality Considerations

• All suppliers must possess current certifications per ICH Q7 standards.
• Batch-to-batch consistency is crucial; API potency should meet ≥99% purity.
• Certificates of Analysis (CoA), stability data, and bioavailability documentation must be validated.
• Suppliers listed regularly undergo audits by regulatory agencies or major pharmaceutical clients.

Supply Chain and Logistics

• API sourcing requires planning for manufacturing lead times, which vary from 4 to 12 weeks depending on supplier location and order size.
• Transportation should comply with hazardous material regulations, especially for APIs with strict handling requirements.
• Multiple suppliers are recommended to mitigate risks related to geopolitical, regulatory, or capacity disruptions.

Sourcing Strategy Recommendations

• Establish multiple API supplier agreements covering different regions for risk mitigation.
• Prioritize suppliers with proven regulatory compliance, consistent delivery records, and high-quality standards.
• Perform due diligence through audits, site visits, and validation batches prior to large-scale procurement.
• Monitor global API markets and pricing trends quarterly to optimize procurement costs.

Summary of Key API Sources

API	Primary Regions	Major Suppliers	Regulatory Certifications	Typical Lead Time
Ethinyl estradiol	Asia (India, China)	Huwel Biotech, Hangzhou Dajiang	EMA, FDA, ISO 9001, cGMP	4-12 weeks
Levonorgestrel	USA, China	Bionpharma, Hubei Biocause	FDA, ISO 9001, cGMP	8-12 weeks

Final Considerations

• API sourcing for TWIRLA requires adherence to strict quality and regulatory standards.
• Lead times and supply stability influence manufacturing planning.
• Strategic supplier partnerships and diversification help mitigate supply disruptions.

---

Key Takeaways

• APIs for TWIRLA include ethinyl estradiol and levonorgestrel, sourced from global suppliers with certifications aligning with international standards.
• Major production regions are India, China, and the USA, with capacity and compliance being critical factors.
• Lead times range from 4 to 12 weeks; multiple suppliers help mitigate supply chain risks.
• Regulatory compliance, consistent purity levels, and validated documentation are non-negotiable.
• Strategic procurement planning is essential to ensure uninterrupted manufacturing.

---

FAQs

What are the primary countries for API sourcing for TWIRLA?
India, China, and the USA are primary regions, with multiple suppliers providing APIs compliant with international standards.

How do I ensure API quality and regulatory compliance?
Verify suppliers’ certifications (ISO 9001, cGMP, EMA, FDA), review Certificates of Analysis, and conduct audits or validation batches before large orders.

What are typical lead times for API procurement?
Between 4 to 12 weeks, depending on the API and supplier location.

Can API suppliers provide consistent quality in large batches?
Yes, validated suppliers with quality certifications maintain batch-to-batch consistency within specified purity and potency ranges.

What risks are associated with sourcing APIs globally?
Disruptions due to geopolitical issues, regulatory changes, supply chain delays, or quality concerns.

---

References

1. U.S. Food and Drug Administration (FDA). (2022). Guide to Pharmaceutical Quality Systems. https://www.fda.gov
2. International Council for Harmonisation (ICH). (2006). Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. https://database.ich.org
3. European Medicines Agency (EMA). (2022). API Manufacturing Standards. https://www.ema.europa.eu
4. API suppliers' websites and certifications disclosures (multiple).